Biotech Values

[steveporsche]

>>That same survival improvement (26%) was enough to get oncologists so hot about Taxotere...<

Actually, Taxotere decreased risk of death by 24%. Great – now I feel like an anally retentive FDA statistician.

"Johns Hopkins Kimmel Cancer Center clinicians were among those at leading institutions that have completed a three-year international study showing that docetaxel, a drug made from yew tree needles, decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy."

http://www.hopkinsmedicine.org/Press_releases/2004/06_07a_04.html